Form 8-K - Current report:
SEC Accession No. 0001193125-23-251090
Filing Date
2023-10-05
Accepted
2023-10-05 07:43:03
Documents
13
Period of Report
2023-10-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d533762d8k.htm   iXBRL 8-K 25853
  Complete submission text file 0001193125-23-251090.txt   177557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amgn-20231005.xsd EX-101.SCH 3290
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20231005_def.xml EX-101.DEF 13060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20231005_lab.xml EX-101.LAB 21662
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20231005_pre.xml EX-101.PRE 13767
7 EXTRACTED XBRL INSTANCE DOCUMENT d533762d8k_htm.xml XML 5294
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 231309835
SIC: 2836 Biological Products, (No Diagnostic Substances)